Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
use within 4 weeks
Reduced caloric intake combined with metabolic changes can cause tiredness, especially in the first month
It is important to note that Phase 2 trials typically exclude participants with significant cardiovascular disease, which limits the generalisability of these safety findings to higher-risk populations
Future studies will be crucial in addressing existing challenges, optimizing dosing regimens, and expanding their applications to maximize their impact on patient care
Progress photos
Discontinuation due to adverse events: 4.1% (4mg) / 6.9% (9mg) / 11.3% (12mg) vs
US$ 27.85
US$ 27.54
US$ 23.70
US$ 26.80
US$ 28.47
US$ 23.81
US$ 25.60
US$ 28.09
